KalVista Pharmaceuticals, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 CGEM
|
Cullinan Oncology, Inc. | $12.52 | $1.29 B | -7.16 | 85 | $0 |
 COGT
|
Cogent Biosciences, Inc. | $9.13 | $802.20 M | -3.37 | 164 | $0 |
 CRNX
|
Crinetics Pharmaceuticals, Inc. | $56.02 | $3.53 B | -11.86 | 290 | $4.01 M |
 CYTK
|
Cytokinetics, Incorporated | $49.10 | $6.05 B | -9.78 | 423 | $7.53 M |
 DICE
|
DICE Therapeutics, Inc. | $47.55 | $2.27 B | -21.91 | 71 | $0 |
 DYN
|
Dyne Therapeutics, Inc. | $29.67 | $3.03 B | -7.77 | 173 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $32.23 | $1.65 B | -11.47 | 108 | $0 |
 GOSS
|
Gossamer Bio, Inc. | $0.70 | $124.06 M | -0.65 | 135 | $0 |
 IMCR
|
Immunocore Holdings plc | $32.23 | $2.08 B | -26.72 | 497 | $249.43 M |
 KRON
|
Kronos Bio, Inc. | $0.90 | $44.62 M | -0.37 | 58 | $6.29 M |
 KRTX
|
Karuna Therapeutics, Inc. | $329.83 | $12.60 B | -28.09 | 339 | $654,000 |
 KURA
|
Kura Oncology, Inc. | $10.79 | $1.66 B | -10.03 | 142 | $0 |
 LRMR
|
Larimar Therapeutics, Inc. | $6.16 | $611.84 M | -9.99 | 42 | $0 |
 LYRA
|
Lyra Therapeutics, Inc. | $0.19 | $19.53 M | -0.27 | 88 | $1.56 M |
 MIRM
|
Mirum Pharmaceuticals, Inc. | $44.70 | $1.18 B | -6.7 | 311 | $186.37 M |
 MRSN
|
Mersana Therapeutics, Inc. | $2.04 | $261.85 M | -1.91 | 123 | $36.86 M |
 NVCT
|
Nuvectis Pharma, Inc. | $5.11 | $116.38 M | -4.5 | 13 | $0 |
 REPL
|
Replimune Group, Inc. | $14.89 | $485.18 M | -2.44 | 331 | $0 |
 SNDX
|
Syndax Pharmaceuticals, Inc. | $16.09 | $1.66 B | -6.02 | 184 | $0 |
 THRX
|
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 |
 VRDN
|
Viridian Therapeutics, Inc. | $20.20 | $776.72 M | -2.71 | 94 | $314,000 |